Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV).


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Nov 2020
Historique:
received: 28 10 2020
revised: 20 11 2020
accepted: 20 11 2020
entrez: 26 11 2020
pubmed: 27 11 2020
medline: 4 3 2021
Statut: epublish

Résumé

Natural killer (NK) cells play a significant and vital role in the first line of defense against infection through their ability to target cells without prior sensitization. They also contribute significantly to the activation and recruitment of both innate and adaptive immune cells through the production of a range of cytokines and chemokines. In the context of cytomegalovirus (CMV) infection, NK cells and CMV have co-evolved side by side to employ several mechanisms to evade one another. However, during this co-evolution the discovery of a subset of long-lived NK cells with enhanced effector potential, increased antibody-dependent responses and the potential to mediate immune memory has revolutionized the field of NK cell biology. The ability of a virus to imprint on the NK cell receptor repertoire resulting in the expansion of diverse, highly functional NK cells to this day remains a significant immunological phenomenon that only occurs in the context of CMV. Here we review our current understanding of the development of these NK cells, commonly referred to as adaptive NK cells and their current role in transplantation, infection, vaccination and cancer immunotherapy to decipher the complex role of CMV in dictating NK cell functional fate.

Identifiants

pubmed: 33238550
pii: ijms21228864
doi: 10.3390/ijms21228864
pmc: PMC7700325
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Western Australia Department of Health
ID : N/A
Organisme : Cancer Council Western Australia
ID : APP1187521
Organisme : Richard Walter Gibbon Medical Research Scholarship
ID : N/A
Organisme : Rachel Kierath Top-Up Scholarship in Pediatric Cancer Research
ID : N/A
Organisme : Australian Government Research Training Program Scholarship: The University of Western Australia
ID : N/A

Références

Immunity. 1999 Nov;11(5):603-13
pubmed: 10591185
Int J Mol Sci. 2019 Jul 24;20(15):
pubmed: 31344940
Blood. 2011 Aug 4;118(5):1402-12
pubmed: 21540462
J Immunol. 2015 May 15;194(10):4657-67
pubmed: 25855356
Clin Transl Immunology. 2017 Jul 07;6(7):e150
pubmed: 28791125
Front Immunol. 2017 Sep 20;8:1176
pubmed: 28979268
J Immunol. 2016 Aug 15;197(4):1100-1110
pubmed: 27412415
Cell Rep. 2016 May 3;15(5):1088-1099
pubmed: 27117418
Blood Cells Mol Dis. 2004 Nov-Dec;33(3):216-21
pubmed: 15528134
Blood. 2016 May 19;127(20):2427-38
pubmed: 26884374
J Allergy Clin Immunol. 2019 Jul;144(1):294-303.e13
pubmed: 30735686
Biol Blood Marrow Transplant. 2014 Jun;20(6):885-90
pubmed: 24583412
Br J Haematol. 2014 Jul;166(2):229-39
pubmed: 24702221
J Exp Med. 2003 Jun 2;197(11):1427-39
pubmed: 12782710
Cell. 2015 Jan 15;160(1-2):37-47
pubmed: 25594173
Vaccines (Basel). 2020 Jun 05;8(2):
pubmed: 32517137
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10990-5
pubmed: 8855296
Front Immunol. 2018 Apr 20;9:686
pubmed: 29731749
J Infect Dis. 2019 Dec 10;:
pubmed: 31821493
J Immunol. 2010 Sep 1;185(5):2808-18
pubmed: 20679529
Immunobiology. 2008;213(3-4):271-83
pubmed: 18406373
Eur J Immunol. 2013 Dec;43(12):3268-78
pubmed: 24030638
Future Virol. 2012 Mar 1;7(3):279-293
pubmed: 23308079
Nature. 1998 Feb 19;391(6669):795-9
pubmed: 9486650
Immunology. 2014 May;142(1):140-50
pubmed: 24843874
Bone Marrow Transplant. 2018 Nov;53(11):1450-1456
pubmed: 29662245
Front Immunol. 2014 Oct 30;5:552
pubmed: 25400639
J Immunol. 2016 Jul 1;197(1):313-25
pubmed: 27233958
Sci Immunol. 2020 Aug 21;5(50):
pubmed: 32826343
J Immunol. 2014 May 15;192(10):4492-6
pubmed: 24740502
Int Immunol. 2004 Jan;16(1):163-8
pubmed: 14688071
Viruses. 2019 Mar 09;11(3):
pubmed: 30857329
PLoS Pathog. 2011 Sep;7(9):e1002268
pubmed: 21966274
Blood. 2004 Dec 1;104(12):3664-71
pubmed: 15304389
Blood. 2012 Jan 12;119(2):399-410
pubmed: 22096237
J Immunol. 2012 May 1;188(9):4412-20
pubmed: 22490439
J Biol Chem. 2013 Mar 22;288(12):8679-90
pubmed: 23335510
Cancer Immunol Res. 2017 Aug;5(8):654-665
pubmed: 28637877
Blood. 2011 Sep 8;118(10):2784-92
pubmed: 21757615
Biol Blood Marrow Transplant. 2016 Feb;22(2):300-306
pubmed: 26371373
Immunol Rev. 2006 Dec;214:155-60
pubmed: 17100883
PLoS Pathog. 2014 Oct 16;10(10):e1004441
pubmed: 25329659
F1000Prime Rep. 2014 May 06;6:28
pubmed: 24860650
J Infect Dis. 2006 Jul 1;194(1):38-41
pubmed: 16741880
Cells. 2020 Jun 09;9(6):
pubmed: 32526891
Blood. 2008 Aug 1;112(3):914-5
pubmed: 18650467
J Immunol. 2015 Oct 1;195(7):3262-72
pubmed: 26283480
Front Immunol. 2017 May 08;8:525
pubmed: 28533779
Clin Cancer Res. 2013 Jul 15;19(14):3844-55
pubmed: 23690482
Nature. 1997 Apr 3;386(6624):446-7
pubmed: 9087399
J Immunol. 2000 May 15;164(10):5019-22
pubmed: 10799855
Bone Marrow Transplant. 2003 Oct;32(8):801-7
pubmed: 14520425
Trends Immunol. 2011 Aug;32(8):364-72
pubmed: 21752715
Clin Transl Immunology. 2020 Jul 16;9(7):e1151
pubmed: 32695339
Eur J Immunol. 2012 Dec;42(12):3256-66
pubmed: 22965785
Eur J Immunol. 2018 Jan;48(1):50-65
pubmed: 28960320
Blood. 2013 Apr 4;121(14):2678-88
pubmed: 23325834
Nat Immunol. 2018 May;19(5):453-463
pubmed: 29632329
Front Immunol. 2019 May 07;10:909
pubmed: 31134055
Eur J Immunol. 1975 Feb;5(2):117-21
pubmed: 1086218
JCI Insight. 2019 Jan 24;4(2):
pubmed: 30674718
Front Immunol. 2019 May 31;10:1205
pubmed: 31214177
J Immunol. 2012 Nov 15;189(10):5082-8
pubmed: 23077239
J Exp Med. 2019 Jun 3;216(6):1280-1290
pubmed: 30979790
Blood. 2012 Mar 15;119(11):2665-74
pubmed: 22180440
J Immunol. 2013 Feb 15;190(4):1402-6
pubmed: 23345329
Am J Transplant. 2020 Mar;20(3):663-676
pubmed: 31612635
J Immunol. 2015 May 15;194(10):4688-97
pubmed: 25855354
Leukemia. 2016 Feb;30(2):456-63
pubmed: 26416461
EMBO J. 2001 Feb 1;20(3):387-96
pubmed: 11157746
Blood. 2010 Mar 18;115(11):2167-76
pubmed: 19965656
J Immunol. 2014 Feb 15;192(4):1471-9
pubmed: 24442432
Cancer Res. 2017 Oct 15;77(20):5664-5675
pubmed: 28790065
Blood. 2016 Jul 21;128(3):456-9
pubmed: 27216219
J Immunol. 2016 May 1;196(9):3818-27
pubmed: 26994220
Immunity. 2015 Mar 17;42(3):431-42
pubmed: 25786175
Cell Rep. 2018 Aug 21;24(8):1967-1976.e4
pubmed: 30134159
Immunity. 2015 Mar 17;42(3):443-56
pubmed: 25786176
AIDS Res Hum Retroviruses. 2012 Aug;28(8):844-51
pubmed: 22074011
J Exp Med. 2011 Jan 17;208(1):13-21
pubmed: 21173105
Blood. 2010 Nov 11;116(19):3865-74
pubmed: 20733159
J Virol. 2013 Dec;87(24):13446-55
pubmed: 24089567
Sci Transl Med. 2016 Sep 21;8(357):357ra123
pubmed: 27655849
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32
pubmed: 21825173
J Immunol. 2007 Mar 1;178(5):2688-98
pubmed: 17312110
Int J Mol Sci. 2020 May 22;21(10):
pubmed: 32455959
Nature. 2009 Jan 29;457(7229):557-61
pubmed: 19136945
Blood. 2006 May 1;107(9):3624-31
pubmed: 16384928
Front Immunol. 2018 Mar 12;9:476
pubmed: 29662484
J Immunol. 2012 May 15;188(10):5054-62
pubmed: 22504653
PLoS Negl Trop Dis. 2016 Mar 03;10(3):e0004499
pubmed: 26938618
J Exp Med. 2018 Sep 3;215(9):2379-2395
pubmed: 30061358
Nat Immunol. 2008 May;9(5):503-10
pubmed: 18425107
J Clin Invest. 2012 Mar;122(3):798-801
pubmed: 22354165
Eur J Immunol. 2017 Jun;47(6):1040-1050
pubmed: 28383105
Haematologica. 2014 Jul;99(7):1248-54
pubmed: 24658822
Science. 2000 Feb 11;287(5455):1031
pubmed: 10669413
Biol Blood Marrow Transplant. 2014 Jan;20(1):46-52
pubmed: 24120526
AIDS. 2005 Nov 4;19(16):1761-9
pubmed: 16227783
Trends Immunol. 2018 Mar;39(3):222-239
pubmed: 29397297
Immunol Cell Biol. 2011 Feb;89(2):216-24
pubmed: 20567250

Auteurs

Samantha Barnes (S)

Telethon Kids Institute, University of Western Australia, Perth Children's Hospital, Nedlands, WA 6009, Australia.
School of Biomedical Sciences, The University of Western Australia, Crawley, WA 6009, Australia.

Ophelia Schilizzi (O)

Telethon Kids Institute, University of Western Australia, Perth Children's Hospital, Nedlands, WA 6009, Australia.
School of Biomedical Sciences, The University of Western Australia, Crawley, WA 6009, Australia.

Katherine M Audsley (KM)

Telethon Kids Institute, University of Western Australia, Perth Children's Hospital, Nedlands, WA 6009, Australia.
School of Biomedical Sciences, The University of Western Australia, Crawley, WA 6009, Australia.

Hannah V Newnes (HV)

Telethon Kids Institute, University of Western Australia, Perth Children's Hospital, Nedlands, WA 6009, Australia.
School of Biomedical Sciences, The University of Western Australia, Crawley, WA 6009, Australia.

Bree Foley (B)

Telethon Kids Institute, University of Western Australia, Perth Children's Hospital, Nedlands, WA 6009, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH